Free Trial

Brookfield (NYSE:BN) Shares Up 1.5% - Should You Buy?

Brookfield logo with Finance background

Key Points

  • Brookfield Corporation's shares increased by 1.5% during mid-day trading, with a last trade price of $46.21, following a previous close at $45.50.
  • JPMorgan recently raised its target price for Brookfield from $48.67 to $55.33 and assigned an "overweight" rating, while the average rating across analysts is a "Buy" with a consensus price target of $52.63.
  • Brookfield has a high dividend payout ratio of 82.76% and recently declared a quarterly dividend of $0.06 per share, resulting in a yield of 0.5%.
  • Five stocks to consider instead of Brookfield.

Brookfield Corporation (NYSE:BN - Get Free Report) shares shot up 1.5% during mid-day trading on Friday . The stock traded as high as $46.56 and last traded at $46.21. 2,619,663 shares changed hands during trading, a decline of 16% from the average session volume of 3,127,712 shares. The stock had previously closed at $45.50.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on BN. JPMorgan Chase & Co. increased their target price on Brookfield from $48.67 to $55.33 and gave the stock an "overweight" rating in a report on Friday, October 3rd. Wall Street Zen raised Brookfield from a "sell" rating to a "hold" rating in a report on Saturday, August 9th. The Goldman Sachs Group started coverage on Brookfield in a report on Tuesday, September 2nd. They set a "buy" rating and a $52.00 target price on the stock. Morgan Stanley set a $54.00 price objective on Brookfield and gave the company an "overweight" rating in a research note on Monday, October 13th. Finally, Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Brookfield in a research note on Friday. Three investment analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of "Buy" and a consensus price target of $52.63.

Check Out Our Latest Analysis on Brookfield

Brookfield Stock Up 1.5%

The company has a debt-to-equity ratio of 1.50, a current ratio of 1.29 and a quick ratio of 1.18. The stock has a market capitalization of $114.35 billion, a P/E ratio of 161.18 and a beta of 1.75. The firm has a 50-day simple moving average of $45.00 and a 200 day simple moving average of $41.44.

Brookfield (NYSE:BN - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.59 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.59. Brookfield had a return on equity of 3.77% and a net margin of 1.11%.The company had revenue of $1.44 billion during the quarter, compared to the consensus estimate of $1.44 billion. On average, equities research analysts forecast that Brookfield Corporation will post 3.85 EPS for the current year.

Brookfield Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, September 29th. Stockholders of record on Friday, September 12th were given a dividend of $0.06 per share. This represents a $0.24 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date was Friday, September 12th. Brookfield's dividend payout ratio (DPR) is 82.76%.

Hedge Funds Weigh In On Brookfield

A number of hedge funds have recently made changes to their positions in the stock. MGO One Seven LLC raised its position in shares of Brookfield by 2.3% during the third quarter. MGO One Seven LLC now owns 44,186 shares of the company's stock worth $3,030,000 after acquiring an additional 1,000 shares during the last quarter. Citizens Financial Group Inc. RI increased its holdings in Brookfield by 777.8% in the third quarter. Citizens Financial Group Inc. RI now owns 45,777 shares of the company's stock worth $3,139,000 after purchasing an additional 40,562 shares in the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA bought a new stake in Brookfield in the third quarter worth approximately $1,203,000. Opal Wealth Advisors LLC increased its holdings in Brookfield by 8.0% in the third quarter. Opal Wealth Advisors LLC now owns 3,470 shares of the company's stock worth $238,000 after purchasing an additional 258 shares in the last quarter. Finally, Culbertson A N & Co. Inc. increased its holdings in Brookfield by 2.3% in the third quarter. Culbertson A N & Co. Inc. now owns 98,404 shares of the company's stock worth $6,749,000 after purchasing an additional 2,218 shares in the last quarter. 61.60% of the stock is currently owned by institutional investors.

About Brookfield

(Get Free Report)

Brookfield Corporation is an alternative asset manager and REIT/Real Estate Investment Manager firm focuses on real estate, renewable power, infrastructure and venture capital and private equity assets. It manages a range of public and private investment products and services for institutional and retail clients.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Brookfield Right Now?

Before you consider Brookfield, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Brookfield wasn't on the list.

While Brookfield currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.